ConvaTec Group Plc (CNVVY) Stock

About ConvaTec Group Plc

ConvaTec Group Plc operates as a global medical technology enterprise, specializing in the development, manufacturing, and distribution of a wide range of healthcare products. The company offers advanced wound care and skin protection solutions, tailored for the effective management of both acute and chronic wounds arising from diverse conditions such as diabetes, immobility, venous disease, traumatic injuries, burns, or complications following surgery. Furthermore, ConvaTec provides comprehensive ostomy care, including specialized devices, accessories, and support services for individuals living with a stoma, often necessitated by conditions like colorectal or bladder cancer, inflammatory bowel disease, obesity, among other medical reasons. Its product portfolio also extends to continence and critical care. This encompasses intermittent urinary catheters and solutions for managing bladder control issues linked to spinal cord injuries, multiple sclerosis, spina bifida, and various other urological disorders. Additionally, the firm supplies medical devices and products specifically designed for use in intensive care units (ICUs) and broader hospital settings. ConvaTec develops sophisticated systems for handling acute fecal incontinence, as well as for precise monitoring of urine production output and intra-abdominal pressure. A diverse array of disposable medical devices is also provided, featuring wound drainage systems, urine collection bags and catheters, equipment for airway management and oxygen/aerosol therapy, suction handles and tubing, gastroenterology tubes, and securement devices. The company is also a supplier of disposable infusion sets to manufacturers of insulin pumps for diabetic patients, and similar sets for pumps employed in continuous infusion treatments for other medical conditions. ConvaTec serves a broad spectrum of clients, including healthcare providers, patients, and other manufacturers. Its products reach both hospital and home healthcare markets, distributed through direct sales, as well as via distributors and wholesalers, targeting pharmacies, hospitals, and various acute and post-acute healthcare service providers. Established in 1978, the company's corporate headquarters are located in Reading, United Kingdom.

ConvaTec Group Plc is headquartered in GB.

ConvaTec Group Plc (CNVVY) stock trades at $11.70 with a market capitalization of $5.72B. The stock is valued at a price-to-earnings (P/E) ratio of 32.81, price-to-book of 3.69, price-to-sales of 2.29. Over the past 52 weeks the stock has ranged between $10.45 and $14.09, and currently trades 17.0% below its 52-week high. It pays a dividend yielding 3.68%.

On profitability, ConvaTec Group Plc generates a return on equity (ROE) of 10.53%, return on capital employed of 12.75%, an operating margin of 16.51%, a net profit margin of 7.17%.

Official website: www.convatecgroup.com